cisplatin,gemcitabine,nivolumab
bms
['hcrn,gu,16-257', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'nivo', 'bladder']
very exciting data from on hcrn gu16-257. fu varies but only 2 pts who initially skipped cystectomy after cr from turbt+gem/cis/nivo developed metastatic dx. the rest were alive with bladder intact or were salvaged in a timely fashion for recurrent disease. #gu23 
Urologic Oncologist, Associate Professor of Urology, Mayo Clinic Arizona, #bladdercancer